They not only target traditional pathological features of AD, such as Aβ plaques, Tau protein abnormalities, and neuroinflammation, but also alleviate anxiety and depression commonly experienced by AD patients [36-38, 44, 204-206]. Here, MAPT is linked to Alzheimer disease.